Perjeta Pertuzumab fiyat 420 mg price in india best at Yourmedikart.
Generic name: pertuzumab [ per-TOO-zoo-mab] Drug class: HER2 inhibitors
Perjeta (pertuzumab) is a targeted therapy used in the treatment of breast cancer. It is specifically designed to target and inhibit the HER2 protein, which can promote the growth of cancer cells in some types of breast cancer. Perjeta is often used in combination with other therapies, such as trastuzumab (Herceptin) and chemotherapy, to treat HER2-positive breast cancer, which is a type of breast cancer that tests positive for human epidermal growth factor receptor 2 (HER2).
Perjeta 420 mg is a crucial component in the treatment of HER2-positive breast cancer, working alongside other medications to prevent cancer cell growth. Pertuzumab 420 mg is the active ingredient, providing targeted therapy for patients in need. The Perjeta precio and availability vary by region, ensuring accessibility for those in need of this advanced treatment option. Similarly, pertuzumab price reflects its value in oncology, offering hope to many.
Perjeta injection is administered in a clinical setting, ensuring proper dosing and monitoring by healthcare professionals. For many, Perjeta 420 mg uses signify a key part of their treatment regimen, aiming for the best possible outcomes in their fight against cancer.
The U.S. Food and Drug Administration (FDA) has approved Perjeta for use in several contexts:
- Neoadjuvant Treatment: This is treatment given before the main treatment. Perjeta, in combination with trastuzumab and chemotherapy, is approved for the treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node-positive) as part of a complete treatment regimen for early breast cancer.
- Adjuvant Treatment: This is treatment given after primary treatments like surgery to increase the chances of a cure. Perjeta, in combination with trastuzumab and chemotherapy, is approved for the adjuvant treatment of HER2-positive early breast cancer at high risk of recurrence.
- Metastatic Treatment: Perjeta 420 mg price For the treatment of patients with HER2-positive metastatic breast cancer, Perjeta is used in combination with trastuzumab and docetaxel (a type of chemotherapy) for those who have not received anti-HER2 therapy or chemotherapy for metastatic disease.
Perjeta works by targeting a different part of the HER2 protein than trastuzumab. The combination of Perjeta and trastuzumab is designed to provide a more comprehensive blockade of HER2 signaling pathways, which can help slow the growth and spread of HER2-positive breast cancer cells.
What is Perjeta?
- Perjeta is a cancer medication that interferes with the growth and spread of cancer cells in the body.
- Perjeta is used together with other cancer medicines (trastuzumab and docetaxel) to treat HER2-positive breast cancer.
- Perjeta may also be use for purposes not listed in this medication guide.
How is Perjeta given?
- Perjeta is give as an infusion into a vein. A healthcare provider will give you this injection.
- Perjeta is usually give once every 3 weeks. Follow your doctor’s instructions.
- Perjeta can cause life-threatening heart problems. Your heart function pertuzumab price may need to check before you start using pertuzumab and during your treatment.
- Benefits of Perjeta Injection
In Breast cancer
Warnings
- Perjeta can cause birth defects or death to the unborn baby. Do not use if you are pregnant. Avoid getting pregnant while using this medicine and for at least 7 months after your last dose.
- Perjeta can cause life-threatening heart problems. Your heart function may need to check before you start using this medicine and during your treatment.
- Call your doctor at once if you have new or worsening cough, shortness of breath, or swelling in your lower legs.
- Before taking this medicine
- Do not use Perjeta if you are allergic to pertuzumab, or if you are pregnant or breastfeeding.
Tell your doctor if you have ever had:
- Heart disease, congestive heart failure, heart rhythm disorder.
- Untreated or uncontrolled high blood pressure (hypertension)
- A heart attack; or
- radiation treatment in your chest area.
- Do not use Perjeta if you are pregnant. It can cause birth defects or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using pertuzumab with trastuzumab, and for at least 7 months after your treatment ends. Tell your doctor right away if you become pregnant.
- If you are pregnant, your name may be list on a pregnancy registry to track the effects of pertuzumab on the baby.
- It may not safe to breastfeed while using Perjeta with trastuzumab, Perjeta Pertuzumab 420 mg and for up to 7 months after your last dose. Ask your doctor about any risk.
Quick tips
- Perjeta 420 mg Injection is use in combination with other medicines for the treatment of breast cancer.
- Do not receive any kind of immunization or vaccination without your doctor’s approval while taking Perjeta 420 mg Injection.
- Use contraceptives, and do not conceive a child (get pregnant) while taking Perjeta 420 mg Injection. Barrier methods of contraception, such as condoms should use during therapy and for 6 months after treatment.
- Drink at least two to three quarts of fluid every 24 hours, unless you are instruct otherwise.
- You may be at risk of infection so try to avoid crowds or people with colds, and report fever or any other signs of infection immediately to your health care provider.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor, and eat small, frequent meals.
- Take anti-diarrhea medication as prescribed by your doctor and eat foods that may help control diarrhea.
- Avoid sun exposure. Wear SPF 15 (or higher) sunblock and protective clothing.
- Inform your doctor if you are pregnant or breastfeeding before taking Perjeta 420 mg Injection.
Perjeta side effects
Get emergency medical help if you have Perjeta 420 mg price signs of an allergic reaction to Perjeta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection. Tell your caregiver right away pertuzumab price if you feel weak, tired, or nauseated, Perjeta Pertuzumab 420 mg or if you have a fast heartbeat, headache, fever, chills, muscle pain, or an unusual taste in your mouth.
Call your doctor at once if you have:
- Dizziness, pounding heartbeats or fluttering in your chest.
- New or worsening cough or shortness of breath.
- Swelling in your lower legs.
- Low blood cell counts – fever, chills, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed; or
- Signs of tumor cell breakdown – Perjeta 420 mg price confusion, weakness, muscle cramps, nausea, vomiting, fast or slow heart rate, decreased urination, tingling in your hands and feet or around your mouth.
Your cancer treatments may delay or pertuzumab price permanently discontinued if you have certain side effects.
Common Perjeta side effects are more likely to occur, such as:
- Nausea, diarrhea.
- Temporary hair loss.
- Fever, low blood cell counts.
- Tiredness.
- Rash; or
- Numbness, tingling, or burning pain in your hands or feet.
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Kidney
Liver
PRODUCT INTRODUCTION
- Firstly Perjeta fiyat 420 mg Injection is use to treat breast cancer. It belongs to group of medicine call monoclonal antibodies.
- Perjeta 420 mg Injection is give as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are treat for and may change from time to time. Secondly pertuzumab price You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
- Hair loss, diarrhea, nausea, and fatigue are some common side effects of this medicine. Pertuzumab price This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are require checking your blood cells along with the heart, liver, and kidney.
- Many other medicines can affect, or be affect by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommend during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
- “There is a Patient Support Program / Patient Assistance Program available in India for this medicine. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.”
Perjeta
Perjeta works by targeting a different part of the HER2 protein than trastuzumab. So, The combination of Perjeta Pertuzumab 420 mg and trastuzumab is design to provide a more comprehensive blockade of HER2 signaling pathways, which can help slow the growth and spread of HER2-positive breast cancer cells.
The use of Perjeta fiyat is associate with certain side effects, Perjeta Pertuzumab 420 mg price the most common of which include diarrhea, hair loss, nausea, fatigue, rash, and peripheral neuropathy. It is important for patients receiving Perjeta to closely monitor by their healthcare provider to manage any side effects and to ensure the therapy is working as intend.
When to contact your doctor or health care provider:
See your doctor right away, day or night, or go to the emergency room. If you experience any of the following symptoms:
- Fever of 100.4º F (38º C) or higher, chills (possible signs of infection)
- So, Signs of a reaction (wheezing, chest tightness, fever, itching, bad cough, blue or gray skin color, seizures,
- Swelling of the face, lips, tongue or throat)
- Thirdly Difficult breathing
- Most Importantly Chest pain or pressure, or a rapid heartbeat
In Addition, Perjeta fiyat 420 mg price The following symptoms require medical attention but are not an emergency. Pertuzumab 420mg Injection Contact your doctor within 24 hours of noticing any of the following:- Firstly Signs of infection: fever, chills, severe sore throat. Ear or sinus pain, cough with or without sputum, painful urination, wounds that do not heal.
- Nausea (interferes with the ability to eat and is not relieve by prescribed medications)
Vomiting (vomiting more than 4-5 times in a 24-hour period) - Diarrhea (4-6 episodes over a 24-hour period)
- Dizziness or lightheadedness
- Terrible headache
- Great weight gain
- Unusual bleeding or bruising
- Extreme fatigue (inability to carry out self-care activities)
- Muscle weakness
- Mouth sores (painful redness, swelling or ulcers)
- Always tell your doctor if you experience any unusual symptoms. pertuzumab price above all common effects
FAQ
What is PERJETA used for?
PERJETA (pertuzumab) is a prescription drug approved for use in combination with Herceptin (trastuzumab) and docetaxel in people with HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received HER2 therapy. or chemotherapy for metastatic breast cancer.
Is PERJETA chemotherapy or immunotherapy?
Perjeta (pertuzumab) is considered a targeted cancer treatment, different from chemotherapy. Chemotherapy works by killing fast-growing cancer cells, but it can also affect normal cells. Perjeta attacks certain proteins in breast cancer cells that cause rapid growth.
How long is PERJETA given?
Patients starting PERJETA and Herceptin in the neoadjuvant setting should continue to receive PERJETA and Herceptin every 3 weeks for a total of 1 year (up to 18 cycles), or until disease recurrence or toxicity-free Administration, each comes.
Is Perjeta effective?
By blocking symptoms, Perjeta can slow or stop the growth of breast cancer. Perjeta and Herceptin are examples of targeted therapy. In addition to blocking HER2 receptors, Perjeta can also help fight breast cancer by prompting the immune system to destroy the cancer cells it binds to.
How many doses of PERJETA?
2.2 Recommended Doses and Schedules The initial dose of PERJETA is 840 mg administered as a 60-minute intravenous infusion, followed every 3 weeks by a dose of 420 mg administered as an intravenous infusion over 30 to 60 minutes.
